Domo Health Secures Angel Investment from Jiawo Capital to Focus on Premium Medical Tourism in Japan

VCBeat (WeChat ID: vcbeat) has learned that Duomu Health, a cross-border medical service platform specializing in high-end Japanese medical tourism, recently secured angel-round investment from Jiawo Capital.

Due to advantages such as proximity, affordable costs, and dietary habits similar to those in China, Japan has become the preferred destination for Chinese citizens engaging in overseas medical tourism. According to a report by the Development Bank of Japan, the number of Chinese visitors traveling to Japan solely for health checkups was projected to exceed 310,000 annually by 2020. Japan’s system for cancer prevention and early detection is among the most advanced globally, with a single comprehensive health screening costing between RMB 20,000 and 30,000.

Duomu Health, established in 2015, is a cross-border medical consulting service firm founded by returnees who studied in Japan. The founder of Duomu Health graduated from Waseda University and previously worked at Nomura Securities. The core team members all have over ten years of experience studying and working in Japan, possessing profound understanding and insight into Japanese medical institutions and healthcare systems.

Meanwhile, Duomu has also engaged renowned medical experts from top-tier (Grade A tertiary) hospitals in Beijing and Shanghai to form a medical advisory team, creating customized service packages tailored to each client’s medical history and lifestyle habits.

Health management products and women’s care products are the two main categories of high-end medical offerings provided by Duomu Health. The health management product line primarily includes premium precision health screenings in Japan (early cancer detection) and overseas high-end medical services. The women’s care product line mainly focuses on anti-aging treatments and oocyte cryopreservation/in vitro fertilization (IVF). It is reported that the partner hospitals collaborating with Duomu Health offer more advanced and patient-centered oocyte cryopreservation and IVF technologies, with relatively lower complication rates and higher success rates.

Duomu Health has established long-term partnerships with hundreds of hospitals in Japan. At select partner medical checkup facilities, Duomu Health customers can also enjoy green channel services that eliminate the need for appointment waiting times.

Jiawo Capital, an investor in Duomu Health, believes that with the increasing transparency of overseas medical industry resources, deepening informatization, improved service efficiency, and the cultivation of internet-based consumer habits, the development of one-stop cross-border healthcare platforms has become an inevitable trend.